TerminatedPhase 2NCT00668564

Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

Studying Alpha-mannosidosis, infantile form

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Masonic Cancer Center, University of Minnesota
Principal Investigator: Paul Orchard, MD
University of Minnesota Medical Center
Intervention: Stem Cell Transplantation(procedure)
Enrollment: 18 enrolled
Eligibility: 21 years · All sexes
Timeline: 2008 – 2010

Study locations (1)

University of Minnesota, Fairview, Minneapolis, Minnesota, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00668564 on ClinicalTrials.gov

← Back to all trials